New approaches to the treatment of Parkinson’s
WuXi AppTec is pleased to participate in the BMCS New Approaches to the Treatment of Parkinson’s meeting, scheduled for November 12, 2025, at Burlington House, Piccadilly, London, United Kingdom.
This one-day event is organised by the Royal Society of Chemistry Biological Medicinal Chemistry Sector (BMCS) in collaboration with Parkinson’s UK, and is dedicated to exploring innovative symptomatic and disease-modifying treatments for Parkinson’s disease, a neurodegenerative disorder affecting over 10 million people globally.
At WuXi AppTec, we provide comprehensive discovery, development, and manufacturing services tailored for neurodegenerative disease therapeutics. Whether your project involves small molecule chemistry, biologics research, analytical / DMPK profiling, formulation & CMC support, or supply of preclinical/early-clinical materials, our integrated platform is designed to accelerate progress while maintaining scientific rigor and regulatory readiness.
We look forward to engaging with researchers, innovators, and stakeholders at the meeting to discuss how our capabilities can support your Parkinson’s-focused programs. To schedule a dedicated meeting with our team, please fill out the form on the right.
Resource Links
Research Chemistry Services
Resource Type: Brochure
WuXi AppTec Biology Services
Resource Type: Brochure
